Table 2 Univariate and multivariate analysis of prognosis of PRCC patients.
From: The effect of the papillary renal cell carcinoma subtype on oncological outcomes
Affecting factors | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
Gender (male vs female) | 1.63 | 0.36–7.46 | 0.523 | – | – | – |
Symptoms (with vs without) | 3.62 | 1.09–12.02 | 0.024 | 2.06 | 0.36–11.70 | 0.415 |
Subtypes (II vs I) | 7.71 | 0.99–59.70 | 0.021 | 2.07 | 0.16–26.32 | 0.573 |
T (T3 vs T1-2) | 31.25 | 9.01–111.11 | < 0.001 | 1.89 | 0.20–16.78 | 0.594 |
N (N1 vs N0) | 17.50 | 4.94–62.02 | < 0.001 | 2.08 | 0.28–15.51 | 0.477 |
M (M1 vs M0) | 7.04 | 1.45–34.48 | 0.005 | 2.14 | 0.23–19.69 | 0.502 |
Stage grouping (III–IV vs I–II) | 66.67 | 13.89–333.33 | < 0.001 | 90.91 | 5.35–999.98 | 0.002 |
WHO/ISUP grading (3–4 vs 1–2) | 3.44 | 1.09–10.87 | 0.025 | 1.70 | 0.39–7.52 | 0.482 |
Surgical method (RN vs NSS) | 6.45 | 1.41–29.41 | 0.006 | 1.41 | 0.21–9.71 | 0.725 |
